Phase II trial of ribociclib and everolimus in p16 low anaplastic thyroid cancer (ATC). Tawfik, B., Gerber, D. E., Burtness, B., Hughes, R. S., Myers, L. L., Sumer, B. D., Truelson, J., Strom, T., Kurian, P., Saleem, S., Pearson, J., Zhu, H., Khan, S. A. AMER SOC CLINICAL ONCOLOGY. 2017

View details for DOI 10.1200/JCO.2017.35.15_suppl.TPS6098

View details for Web of Science ID 000411931705094